E.U. biotech quartet wins $5.2M for artificial liver research
A group of European biotechnology developers won $5.2 million (€4.2 million) to advance their collaborative work on artificial liver tissue.
The consortium is working on a "standardized, reproducible bioartificial liver organoid" using a healthy human liver as the template.
The "Re-Liver" program is a collaboration between Medicyte, The Electrospinning Company, and the Universities of Manchester, U.K., and Pisa, Italy.
Imaging software maker Medipattern closes 1st tranche of private placement
Toronto-based Medipattern raised $1.9 million through sales of nearly 7.2 million units of paired common shares and half-shares at 25¢ apiece, closing its 1st trance of private placement financing.
CartiHeal raises $10 million for cartilage regenerating technology
Israeli regenerative devices maker CartiHeal raised $5 million in cash and $5 million in options to accelerate development of its cartilage regeneration portfolio.